CVS HEALTH CORPORATION Investment Income, Net
CVS HEALTH CORPORATION (CVS) reported Investment Income, Net of $641.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-05
- CVS HEALTH CORPORATION investment income, net for the quarter ending 2026-06-30 was $641.00M, a 31.62% increase year-over-year.
- CVS HEALTH CORPORATION investment income, net for the quarter ending 2026-03-31 was $574.00M, a 10.38% increase year-over-year.
- CVS HEALTH CORPORATION investment income, net for the quarter ending 2025-12-31 was $594.00M, a 21.32% decline year-over-year.
- CVS HEALTH CORPORATION investment income, net for the quarter ending 2025-09-30 was $632.00M, a 14.91% increase year-over-year.
- CVS HEALTH CORPORATION investment income, net for fiscal 2025 was $2.23B, a 3.72% increase from fiscal 2024.
- CVS HEALTH CORPORATION investment income, net for fiscal 2024 was $2.15B, a 86.73% increase from fiscal 2023.
- CVS HEALTH CORPORATION investment income, net for fiscal 2023 was $1.15B, a 37.59% increase from fiscal 2022.
- CVS HEALTH CORPORATION investment income, net for fiscal 2022 was $838.00M, a 30.11% decline from fiscal 2021.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $641.00M 10-Q · filed 2026-08-05 | $1.22B 10-Q · filed 2026-08-05 | $1.81B derived: sum of 3 quarters · filed 2026-08-05 | $2.44B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $574.00M 10-Q · filed 2026-05-06 | $1.17B derived: sum of 2 quarters · filed 2026-05-06 | $1.80B derived: sum of 3 quarters · filed 2026-05-06 | $2.29B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $594.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.23B derived: sum of 2 quarters · filed 2026-02-10 | $1.71B derived: sum of 3 quarters · filed 2026-08-05 | $2.23B 10-K · filed 2026-02-10 |
| 2025-09-30 | $632.00M 10-Q · filed 2025-10-29 | $1.12B derived: sum of 2 quarters · filed 2026-08-05 | $1.64B 10-Q · filed 2025-10-29 | $2.39B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $487.00M 10-Q · filed 2026-08-05 | $1.01B 10-Q · filed 2026-08-05 | $1.76B derived: sum of 3 quarters · filed 2026-08-05 | $2.31B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $520.00M 10-Q · filed 2026-05-06 | $1.27B derived: sum of 2 quarters · filed 2026-05-06 | $1.82B derived: sum of 3 quarters · filed 2026-05-06 | $2.22B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $755.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.30B derived: sum of 2 quarters · filed 2026-02-10 | $1.70B derived: sum of 3 quarters · filed 2026-02-10 | $2.15B 10-K · filed 2026-02-10 |
| 2024-09-30 | $550.00M 10-Q · filed 2025-10-29 | $944.00M derived: sum of 2 quarters · filed 2025-10-29 | $1.40B 10-Q · filed 2025-10-29 | $1.67B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $394.00M 10-Q · filed 2025-07-31 | $848.00M 10-Q · filed 2025-07-31 | $1.12B derived: sum of 3 quarters · filed 2026-02-10 | $1.39B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $454.00M 10-Q · filed 2025-05-01 | $722.00M derived: sum of 2 quarters · filed 2026-02-10 | $999.00M derived: sum of 3 quarters · filed 2026-02-10 | $1.27B derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $268.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $545.00M derived: sum of 2 quarters · filed 2026-02-10 | $819.00M derived: sum of 3 quarters · filed 2026-02-10 | $1.15B 10-K · filed 2026-02-10 |
| 2023-09-30 | $277.00M 10-Q · filed 2024-11-06 | $551.00M derived: sum of 2 quarters · filed 2024-11-06 | $885.00M 10-Q · filed 2024-11-06 | $1.21B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $274.00M 10-Q · filed 2024-08-07 | $608.00M 10-Q · filed 2024-08-07 | $931.00M derived: sum of 3 quarters · filed 2025-02-12 | $1.13B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $334.00M 10-Q · filed 2024-05-01 | $657.00M derived: sum of 2 quarters · filed 2025-02-12 | $858.00M derived: sum of 3 quarters · filed 2025-02-12 | $1.00B derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $323.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $524.00M derived: sum of 2 quarters · filed 2025-02-12 | $670.00M derived: sum of 3 quarters · filed 2025-02-12 | $838.00M 10-K · filed 2025-02-12 |
| 2022-09-30 | $201.00M 10-Q · filed 2023-11-01 | $347.00M derived: sum of 2 quarters · filed 2023-11-01 | $515.00M 10-Q · filed 2023-11-01 | $882.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | $146.00M 10-Q · filed 2023-08-02 | $314.00M 10-Q · filed 2023-08-02 | $681.00M derived: sum of 3 quarters · filed 2024-02-07 | $927.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | $168.00M 10-Q · filed 2023-05-03 | $535.00M derived: sum of 2 quarters · filed 2024-02-07 | $781.00M derived: sum of 3 quarters · filed 2024-02-07 | $1.07B derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $367.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $613.00M derived: sum of 2 quarters · filed 2024-02-07 | $902.00M derived: sum of 3 quarters · filed 2024-02-07 | $1.20B 10-K · filed 2024-02-07 |
| 2021-09-30 | $246.00M 10-Q · filed 2022-11-02 | $535.00M derived: sum of 2 quarters · filed 2022-11-02 | $832.00M 10-Q · filed 2022-11-02 | $1.08B derived: sum of 4 quarters · filed 2023-05-25 |
| 2021-06-30 | $289.00M 10-Q · filed 2022-08-03 | $586.00M 10-Q · filed 2022-08-03 | $834.00M derived: sum of 3 quarters · filed 2023-05-25 | $1.04B derived: sum of 4 quarters · filed 2023-05-25 |
| 2021-03-31 | $297.00M 10-Q · filed 2022-05-04 | $545.00M derived: sum of 2 quarters · filed 2023-05-25 | $749.00M derived: sum of 3 quarters · filed 2023-05-25 | $933.00M derived: sum of 4 quarters · filed 2023-05-25 |
| 2020-12-31 | $248.00M derived: 8-K 12 month − 10-Q 9 month · filed 2023-05-25 | $452.00M derived: sum of 2 quarters · filed 2023-05-25 | $636.00M derived: sum of 3 quarters · filed 2023-05-25 | $798.00M 8-K · filed 2023-05-25 |
| 2020-09-30 | $204.00M 10-Q · filed 2021-11-03 | $388.00M derived: sum of 2 quarters · filed 2021-11-03 | $550.00M 10-Q · filed 2021-11-03 | $756.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | $184.00M 10-Q · filed 2021-08-04 | $346.00M 10-Q · filed 2021-08-04 | $552.00M derived: sum of 3 quarters · filed 2022-02-09 | $815.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | $162.00M 10-Q · filed 2021-05-04 | $368.00M derived: sum of 2 quarters · filed 2022-02-09 | $631.00M derived: sum of 3 quarters · filed 2022-02-09 | $924.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | $206.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $469.00M derived: sum of 2 quarters · filed 2022-02-09 | $762.00M derived: sum of 3 quarters · filed 2022-02-09 | $1.01B 10-K · filed 2022-02-09 |
| 2019-09-30 | $263.00M 10-Q · filed 2020-11-06 | $556.00M derived: sum of 2 quarters · filed 2020-11-06 | $805.00M 10-Q · filed 2020-11-06 | $980.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $293.00M 10-Q · filed 2020-08-05 | $542.00M 10-Q · filed 2020-08-05 | $717.00M derived: sum of 3 quarters · filed 2021-02-16 | $938.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $249.00M 10-Q · filed 2020-05-06 | $424.00M derived: sum of 2 quarters · filed 2021-02-16 | $645.00M derived: sum of 3 quarters · filed 2021-02-16 | $859.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $175.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $396.00M derived: sum of 2 quarters · filed 2021-02-16 | $610.00M derived: sum of 3 quarters · filed 2021-02-16 | $660.00M 10-K · filed 2021-02-16 |
| 2018-09-30 | $221.00M 10-Q · filed 2019-11-06 | $435.00M derived: sum of 2 quarters · filed 2019-11-06 | $485.00M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $214.00M 10-Q · filed 2019-08-07 | $264.00M 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $50.00M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |